Mediclinic International plc Director Declaration (9030H)
November 20 2018 - 5:00AM
UK Regulatory
TIDMMDC
RNS Number : 9030H
Mediclinic International plc
20 November 2018
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic", the "Company" or the "Group")
20 November 2018
DIRECTOR DECLARATION
In accordance with LR.9.6.14 (2), the Company announces that Mr
Danie Meintjes has been appointed to the boards of Capitec Bank
Holdings Limited ("Capitec") and Capitec Bank Limited ("Capitec
Bank") as a Non-Executive Director with effect from 28 November
2018. Capitec is a bank controlling company and is listed on the
South African Johannesburg Stock Exchange ("JSE") equity market.
Capitec Bank, a wholly-owned subsidiary of Capitec, is listed on
the JSE bond market.
About Mediclinic International plc
Mediclinic is an international private healthcare services group
with operating divisions in Switzerland, Southern Africa (South
Africa and Namibia) and the United Arab Emirates. Its core purpose
is to enhance the quality of life of patients by providing acute
care, specialist-orientated, multi-disciplinary healthcare
services. Mediclinic also holds a 29.9% interest in Spire
Healthcare Group plc, an LSE-listed and UK-based private healthcare
group.
Mediclinic comprises 76 hospitals and 30 clinics. Hirslanden
operates 18 private hospitals and 4 clinics in Switzerland with
more than 1 900 inpatient beds; Mediclinic Southern Africa operates
48 hospitals and 4 day clinics throughout South Africa and 3
hospitals in Namibia with more than 8 100 inpatient beds in total;
and Mediclinic Middle East operates 7 hospitals and 22 clinics with
more than 900 inpatient beds in the United Arab Emirates.
Mediclinic has a primary listing on the Main Market of the LSE
in the United Kingdom, with secondary listings on the JSE in South
Africa and the NSX in Namibia.
For further information, please contact:
Company Secretary, Link Company Matters Limited
Jayne Meacham / Caroline Emmet
+44 (0)20 7954 9569
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Brett Pollard/Debbie Scott - UK
+44 (0)20 3727 1000
Sherryn Schooling - South Africa
+27 (0)21 487 9000
Registered address: 6th Floor, 65 Gresham Street, London, EC2V
7NQ, United Kingdom
Website: www.mediclinic.com
Joint corporate brokers: Morgan Stanley & Co International
plc and UBS Investment Bank
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank
Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RDNBMBMTMBTTBTP
(END) Dow Jones Newswires
November 20, 2018 06:00 ET (11:00 GMT)
Mediclinic (LSE:MDC)
Historical Stock Chart
From Apr 2024 to May 2024
Mediclinic (LSE:MDC)
Historical Stock Chart
From May 2023 to May 2024